Literature DB >> 23014694

Acute vision loss revealing central nervous system aggressive myelomatosis.

Georgia Kaiafa, Kyriaki Chalvatzi, Michael D Diamantidis, Virginia Voulgaridou, Ioannis Kostopoulos, Anna Kalogera-Fountzila, Triantafyllia Koletsa, Vaia Bougatsa, Antigoni Archonti, Vasilios Perifanis.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23014694     DOI： 10.1007/s00415-012-6682-4

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  7 in total

Review 1.  Myeloma of the central nervous system: association with high-risk chromosomal abnormalities, plasmablastic morphology and extramedullary manifestations.

Authors:  Athanasios B-T Fassas; Firas Muwalla; Tanya Berryman; Riad Benramdane; Lija Joseph; Elias Anaissie; Rajesh Sethi; Raman Desikan; David Siegel; Ashraf Badros; Amir Toor; Maurizio Zangari; Christopher Morris; Edgardo Angtuaco; Sajini Mathew; Carla Wilson; Aubrey Hough; Sami Harik; Bart Barlogie; Guido Tricot
Journal:  Br J Haematol       Date:  2002-04       Impact factor: 6.998

2.  Multiple myeloma involving the central nervous system: a report of two cases with unusual manifestations.

Authors:  Charalampos Pontikoglou; Constantine Fragos; Eleftheria Kolyvaki; George Samonis; George D Eliopoulos; Helen A Papadaki
Journal:  Leuk Lymphoma       Date:  2005-05

3.  International uniform response criteria for multiple myeloma.

Authors:  B G M Durie; J-L Harousseau; J S Miguel; J Bladé; B Barlogie; K Anderson; M Gertz; M Dimopoulos; J Westin; P Sonneveld; H Ludwig; G Gahrton; M Beksac; J Crowley; A Belch; M Boccadaro; M Cavo; I Turesson; D Joshua; D Vesole; R Kyle; R Alexanian; G Tricot; M Attal; G Merlini; R Powles; P Richardson; K Shimizu; P Tosi; G Morgan; S V Rajkumar
Journal:  Leukemia       Date:  2006-07-20       Impact factor: 11.528

Review 4.  Plasma cell leukemia.

Authors:  Flavio Albarracin; Rafael Fonseca
Journal:  Blood Rev       Date:  2011-02-03       Impact factor: 8.250

5.  The absence of CD56 (NCAM) on malignant plasma cells is a hallmark of plasma cell leukemia and of a special subset of multiple myeloma.

Authors:  C Pellat-Deceunynck; S Barillé; G Jego; D Puthier; N Robillard; D Pineau; M J Rapp; J L Harousseau; M Amiot; R Bataille
Journal:  Leukemia       Date:  1998-12       Impact factor: 11.528

Review 6.  Central nervous system myelomatosis: review of the literature.

Authors:  Laurens Nieuwenhuizen; Douwe H Biesma
Journal:  Eur J Haematol       Date:  2007-10-23       Impact factor: 2.997

7.  Multiple myeloma invasion of the central nervous system.

Authors:  Keith O Schluterman; Athanasios B-T Fassas; Rudy L Van Hemert; Sami I Harik
Journal:  Arch Neurol       Date:  2004-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.